Literature DB >> 32030303

Radiation doses in esophageal cancer.

Susan A Smith1, Matthew P Fox2.   

Abstract

Entities:  

Year:  2019        PMID: 32030303      PMCID: PMC6988048          DOI: 10.21037/jtd.2019.12.96

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  7 in total

1.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

2.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

3.  Influence of Neoadjuvant Radiation Dose on Patients Undergoing Esophagectomy and Survival in Locally Advanced Esophageal Cancer.

Authors:  Mickey S Ising; Katy Marino; Jaimin R Trivedi; Adam A Rojan; Neal E Dunlap; Victor van Berkel; Matthew P Fox
Journal:  J Gastrointest Surg       Date:  2019-02-20       Impact factor: 3.452

4.  Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Jaffer A Ajani; Thomas A D'Amico; David J Bentrem; Joseph Chao; Carlos Corvera; Prajnan Das; Crystal S Denlinger; Peter C Enzinger; Paul Fanta; Farhood Farjah; Hans Gerdes; Michael Gibson; Robert E Glasgow; James A Hayman; Steven Hochwald; Wayne L Hofstetter; David H Ilson; Dawn Jaroszewski; Kimberly L Johung; Rajesh N Keswani; Lawrence R Kleinberg; Stephen Leong; Quan P Ly; Kristina A Matkowskyj; Michael McNamara; Mary F Mulcahy; Ravi K Paluri; Haeseong Park; Kyle A Perry; Jose Pimiento; George A Poultsides; Robert Roses; Vivian E Strong; Georgia Wiesner; Christopher G Willett; Cameron D Wright; Nicole R McMillian; Lenora A Pluchino
Journal:  J Natl Compr Canc Netw       Date:  2019-07-01       Impact factor: 11.908

5.  INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.

Authors:  Bruce D Minsky; Thomas F Pajak; Robert J Ginsberg; Thomas M Pisansky; James Martenson; Ritsuko Komaki; Gordon Okawara; Seth A Rosenthal; David P Kelsen
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

6.  Induction Radiation Therapy for Esophageal Cancer: Does Dose Affect Outcomes?

Authors:  Tara R Semenkovich; Pamela P Samson; Jessica L Hudson; Melanie Subramanian; Bryan F Meyers; Benjamin D Kozower; Daniel Kreisel; G Alexander Patterson; Clifford G Robinson; Jeffrey D Bradley; Varun Puri
Journal:  Ann Thorac Surg       Date:  2018-11-13       Impact factor: 4.330

7.  Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

Authors:  Joel Tepper; Mark J Krasna; Donna Niedzwiecki; Donna Hollis; Carolyn E Reed; Richard Goldberg; Krystyna Kiel; Christopher Willett; David Sugarbaker; Robert Mayer
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544

  7 in total
  1 in total

1.  The efficacy and safety of simultaneous integrated dose reduction in clinical target volume with intensity-modulated radiotherapy for patients with locally advanced esophageal squamous cell carcinoma.

Authors:  Jingjing Zhao; Tongda Lei; Tian Zhang; Xi Chen; Jie Dong; Yong Guan; Jing Wang; Hui Wei; Puchun Er; Dong Han; Xiaoying Wei; Zhoubo Guo; Qingwu Du; Jun Wang; Ningbo Liu; Yongchun Song; Zhiyong Yuan; Lujun Zhao; Wencheng Zhang; Qingsong Pang; Ping Wang
Journal:  Ann Transl Med       Date:  2020-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.